BEDMINSTER, NJ —
The American Diabetes Association is honoring Integrium Clinical Research at its 16th annual gala on November 5 at the Grounds for Sculpture in Hamilton, New Jersey. The gala not only recognizes leaders and pioneering researchers in diabetes but also aims to raise funds needed to expand and continue outreach programs in New Jersey.
Integrium is a contract research organization (CRO) with a therapeutic focus on cardiovascular and metabolic diseases. Executive Director of the American Diabetes Association in New Jersey, Mathieu N. Nelessen says Integrium earned this honor for its successful efforts to speed the development of new and more effective drug treatment for diabetes.
Integrium has conducted 18 clinical trials of treatment for diabetes at 557 study sites. In addition to trials targeting diabetes, Integrium has conducted more than 100 cardiovascular and renal disease trials, which have an impact on diabetes care since diabetes is a leading cause of kidney failure and more than two-thirds of people with diabetes die of heart disease or stroke.
Integrium founder Dr. David H. G. Smith observes that the diabetes epidemic is not abating. “A staggering 366 million people worldwide suffer from diabetes. One in ten American adults has diabetes and that number may triple in the coming decades. The disease is the seventh leading cause of death in the U.S. More than half a million people in New Jersey have been diagnosed with diabetes and an estimated 200,000 have diabetes but have not yet been diagnosed.”
The United States is in the throes of a diabetes epidemic. An estimated 24 million children and adults have diabetes. Another 57 million others have pre-diabetes, elevated blood glucose levels that increase their risk of developing diabetes, heart disease and stroke.
Diabetes is a leading cause of kidney failure, blindness, amputations and pregnancy complications and is the seventh leading cause of death in the U.S. Timely diagnosis and effective treatment help to prevent and reduce the symptoms and life-threatening complications of diabetes.
About the American Diabetes Association
The American Diabetes Association funds research to prevent, cure and manage diabetes; deliver services to hundreds of communities; provide objective and credible information and; is the voice for persons denied their rights because of diabetes.
About Integrium, LLC.
Integrium is a full-service clinical research organization (CRO) designing, conducting, and analyzing clinical trials for pharmaceutical research in dermatology, cardiovascular, and metabolic disorders. It is committed to focused, specialized, and long-term personalized service to its partners. It has a strong reputation for delivering high-quality management of clinical development programs. Combining the Integrium Clinical Excellence (ICE) study start-up and management methodology and therapeutic expertise leads sponsors to more confident, better-informed drug and device development decisions. For more information please visit http://www.integrium.com.
© Marketwire 2011
Article source: http://www.msnbc.msn.com/id/44842515